30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Medacta Gains CE Mark for Lateralized Glenosphere -

Medacta received CE Mark approval or a lateralized glenosphere component, expanding its range of reverse shoulder replacement options. The device features a more lateralized centre of rotation vs. the standard glenosphere presently marketed with the Medacta Shoulder. The lateralization can support an improved range of motion, as well as a reduced risk of scapular notching. Medacta's modular shoulder system, pictured below, includes a range of sizes, adjustable offset and anatomic and reverse configurations. It is compatible with the company's CT-based MyShoulder 3D preoperative planning solution, with patient-specific humeral and glenoid guides. (Medacta International, 10/9/19)